Robert Lakin

Robert Lakin

A journalist — both writer and editor — Robert has covered markets and economies for more than 20 years. His previous gigs include Bloomberg News, where he was emerging markets editor in Tel Aviv, McKinsey & Co. and McDonald & Company Investments, where he was equities research editor.

His deep experience includes covering startups, emerging markets, financial services, and capital markets.

He writes a Substack newsletter, TLV Strategist, which covers the Israel business scene.

Recent Articles

Klarna Stock Benefits from Growing Trends in Retail and Fintech

Regardless of whether you invest in Klarna stock in the near future, keep the buy now, pay later fintech in your sights. Here's why.

Hexo CFO Calls it Quits After 5 Months on the Job

The departure comes 10 months after the pot producer said in a release that a CFO transition plan was in place for Hexo.

Investors Need to Change Their Perspective on Chinese Stocks

China's rebounding domestic economy has created incredible opportunities investors. Based on the holdings of GAM China Evolution Fund, here are some Chinese stocks from the consumer, financial and healthcare sectors, including several less-familiar names.

Teva Pharmaceutical Industries Ltd ADR (TEVA) Names Kare Schultz As CEO

Teva ended its leadership uncertainty with the selection of long-time pharma exec Kåre Schultz as CEO, TEVA stock is up this morning.

Blue Apron IPO: The Meal Delivery Service Files to Go Public

Meal-kit provider Blue Apron Holdings, Inc. filed to go public after growing sales to $800 million last year.